JFG
NKGNW

Jefferies Financial Group’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Jefferies Financial Group’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,000
Closed -$2.83K – 2119
2023
Q4 		$2.83K Hold
35,000
– – ﹤0.01% 1630
2023
Q3 		$13.8K Hold
35,000
– – ﹤0.01% 1538
2023
Q2 		$7K Hold
35,000
– – ﹤0.01% 1595
2023
Q1 		$4.9K Hold
35,000
– – ﹤0.01% 1563
2022
Q4 		$2.97K Buy
+35,000
New +$2.94K ﹤0.01% 1493

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Jefferies Financial Group's NKGNW Position: Q1 2024 in Review

Jefferies Financial Group sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2024, closing a stake of 35,000 shares — an estimated $2.83K sold.

Jefferies Financial Group first reported a position in NKGNW in Q4 2022 and held it in 5 quarters. The position peaked at $13.8K in Q3 2023. 30 funds tracked by Wall St. Rank hold NKGNW as of Q1 2024.

  • Jefferies Financial Group reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 35,000 NKGen Biotech, Inc. Warrants shares in Q1 2024, an estimated $2.83K.
  • Jefferies Financial Group first reported a position in NKGen Biotech, Inc. Warrants in Q4 2022 and held it in 5 quarters.
  • Jefferies Financial Group's NKGen Biotech, Inc. Warrants position peaked at $13.8K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2024.

Based on Jefferies Financial Group's 13F filing for Q1 2024, filed 13 May 2024.